21
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
MedVax is a biopharmaceutical company discovering and commercializing cancer vaccines.
About the Company
MedVax's portfolio includes an autologous Adenovirus P53 dendritic cell vaccine in two FDA Phase II clinical trials, in Small Cell Lung Cancer, and Breast Cancer. MedVax also has a chimeric HER2 Peptide vaccine that is concluding a 2nd Phase I trial, and preparing for a Phase II trial.
